Author:
Pop Andreea S.,Gomez-Mancilla Baltazar,Neri Giovanni,Willemsen Rob,Gasparini Fabrizio
Publisher
Springer Science and Business Media LLC
Reference120 articles.
1. Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, Nakanishi S (1992) Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 267:13361–13368
2. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J (1993) Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4:147–153
3. Bakker CE, Verheij C, Willemsen R, van der Helm R, Erlemans F, Vermey M, Ygrave A, Oogeveen AT, Oostra BA (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch–Belgian Fragile X Consortium. Cell 78:23–33
4. Bear MF, Huber KM, Warren ST (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370–377
5. Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT (2008) Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 29:293–302